Good evening,
 
 

Good evening,

We’ve got ourselves a raid. A PE buyer had UBS gobbling up a massive 19.9 per cent stake in IVF provider Virtus Health on Monday night.

UBS was ringing around offering institutional investors a 36 per cent premium for the $121 million Virtus Health stake and, from what we hear, had little trouble finding sellers.

The brokers were working to a 7pm deadline, but fund managers were being turned down not long past 6pm.

It looks likely the mystery buyer will make a play for the rest of Virtus. Our tip is it will be a fund familiar with the space – how else would you get comfortable buying up such a large stake with no due diligence requirement?

Elsewhere, CSL is just the latest in a monster year of M&A deals; First Sentier and Palisade Investment Partners are expected to bid for GeelongPort; and tech company CT4 has completed a second pre-IPO raising.

Happy reading,

Anthony Macdonald, Yolanda Redrup and Kanika Sood
Street Talk editors

 
The Australian Financial Review
TwitterInstagramLinkedInFacebook

You have received this email because you are subscribed to Street Talk First Look with the email address: newsletter@newslettercollector.com

  Manage Subscriptions     Unsubscribe     Privacy Policy     Contact Us  

© 2021 The Australian Financial Review

1 Denison Street North Sydney, NSW 2060 Australia

 
Nine Entertainment, 1 Denison St, North Sydney, NSW, 2060, Australia Profile center